%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2021-04-13T09:27:58-04:00
2021-04-13T09:28:04-04:00
2021-04-13T09:28:04-04:00
Adobe InDesign CC 13.1 (Windows)
uuid:fe870afd-aa55-41be-9504-edb5199d46e1
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
xmp.id:30485a6a-6db8-d842-8bb4-50b4ac390bf8
proof:pdf
xmp.iid:28a924f1-7e75-3a4d-8cdd-953c61241f26
xmp.did:6736fa7d-975d-9a43-906c-fc4b40e1c273
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 13.1 (Windows)
/
2021-04-13T09:27:58-04:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
12 0 obj
<>
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
6 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
14 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
40 0 obj
<>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc 8.5 0 0 8.5 171.2281 532.438 Tm
(1.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Which ECG \037nding is more common in elite)-10 ( )]TJ
0 -1.2 Td
(women athletes?)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
[(a. V)86 (oltage criteria for left ventricular )]TJ
0 -1.2 Td
(hypertrophy)Tj
0 -1.729 Td
[(b. V)86 (oltage criteria for right ventricular )]TJ
0 -1.2 Td
(hypertrophy)Tj
0 -1.729 Td
(c. Early repolarization)Tj
0 -1.729 Td
(d. Abnormal T wave inversions)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(2.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(In an analysis of a large national database,)-10 ( )]TJ
0 -1.2 Td
[(acute myocardial infarction patients without)-10 ( )]TJ
0 -1.2 Td
[(the standard risk factors for atherosclerosis)-10 ( )]TJ
0 -1.2 Td
(made up what percentage of the population?)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. 0%)Tj
0 -1.729 Td
(b. 5%)Tj
0 -1.729 Td
(c. 15%)Tj
0 -1.729 Td
(d. 35%)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(3.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Randomized trial data showed inclisiran)-10 ( )]TJ
0 -1.2 Td
[(injected twice a year reduces LDL cholesterol)-10 ( )]TJ
0 -1.2 Td
[(in patients on maximally tolerated statin)-10 ( )]TJ
0 -1.2 Td
(therapy by about:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. 10%. )Tj
0 -1.729 Td
(b. 25%.)Tj
22.896 33.882 Td
(c. 50%.)Tj
0 -1.729 Td
(d. 75%.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(4.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(In patients with the more common)-10 ( )]TJ
0 -1.2 Td
[(hyperadrenergic form of postural orthostatic)-9.9 ( )]TJ
0 -1.2 Td
[(tachycardia syndrome, ivabradine therapy)-10 ( )]TJ
0 -1.2 Td
(resulted in:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. a slower standing heart rate.)Tj
0 -1.729 Td
(b. a higher standing blood pressure.)Tj
0 -1.729 Td
(c. less fatigue.)Tj
0 -1.729 Td
(d. higher plasma norepinephrine levels.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(5.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(A large European registry of younger patients)-9.9 ( )]TJ
0 -1.2 Td
[(undergoing the Ross procedure for aortic valve)-10 ( )]TJ
0 -1.2 Td
(disease has shown a 10-year survival rate of:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. 100%.)Tj
0 -1.729 Td
(b. 95%.)Tj
0 -1.729 Td
(c. 80%.)Tj
0 -1.729 Td
(d. 67%.)Tj
ET
endstream
endobj
42 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
/CS0 cs 0.07 scn
/GS0 gs
18 99.617 120.33 656.383 re
f
18 36 539.325 53.473 re
f
BT
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 7 0 0 7 27.8983 78.3659 Tm
(Interested in reprints or posting an article to your )Tj
0 -1.143 Td
[(company)-55.8 (\222s site? There are numerous opportunities for )]TJ
0 -1.143 Td
(you to leverage editorial recognition for the benefit of )Tj
0 -1.143 Td
(your brand. Call us at \(800\) 688-2421 or email us at )Tj
0 -1.143 Td
(reliasmedia)Tj
/C2_0 1 Tf
<0014>Tj
/TT0 1 Tf
(@gmail.com.)Tj
25.217 4.571 Td
(Discounts are available for group subscriptions, multiple )Tj
0 -1.143 Td
(copies, site licenses, or electronic distribution. For pricing )Tj
0 -1.143 Td
(information, please contact our Group Account Managers )Tj
0 -1.143 Td
(at groups@reliasmedia.com or \(866\) 213-0844.)Tj
19.248 0 Td
( )Tj
5.969 3.429 Td
[(T)175 (o reproduce any part of R)17.6 (elias Media newsletters for )]TJ
0 -1.143 Td
(educational purposes, please contact The Copyright )Tj
0 -1.143 Td
(Clearance Center for permission at info@copyright.com )Tj
0 -1.143 Td
(or \(978\) 750-8400.)Tj
ET
/CS0 CS 1 SCN
3 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 138.6633 754.5 cm
0 0 m
437.337 0 l
S
Q
/CS0 cs 1 scn
164.425 173.113 391.566 17.367 re
f
BT
0 0 0 0 k
12 0 0 12 305.3203 177.875 Tm
(CME/CE OBJECTIVES)Tj
ET
/CS0 cs 1 scn
163.328 549.32 392.414 17.367 re
f
0.25 w
163.391 229.365 392.225 319.83 re
S
BT
0 0 0 0 k
12 0 0 12 304.0168 553.4156 Tm
(CME/CE QUESTIONS)Tj
ET
/CS0 cs 0.07 scn
163.266 611.28 392.475 118.6 re
f
BT
0 0 0 1 k
/GS1 gs
/TT1 1 Tf
-0.02 Tc 9 0 0 9 171.2281 712.446 Tm
[(T)174.8 (o earn credit for this activity)87 (, please follow these instructions:)]TJ
0 Tc 22.102 0 Td
( )Tj
-0.02 Tc -22.102 -1.222 Td
[(1. R)17.5 (ead and study the activity)87 (, using the provided references for further research.)]TJ
0 Tc 29.127 0 Td
( )Tj
-0.02 Tc -29.127 -1.222 Td
[(2. L)17.4 (og on to )]TJ
/TT0 1 Tf
0.02 Tw [(R)17.6 (eliasMedia.com)]TJ
/TT1 1 Tf
0 Tw [( and click on My Account. F)35.9 (irst-time users must register on the site. T)174.8 (ests are taken)-19.9 ( )]TJ
0 -1.222 Td
[(after each issue.)-19.9 ( )]TJ
0 Tc 5.952 0 Td
( )Tj
-0.02 Tc -5.952 -1.222 Td
[(3. P)54.7 (ass the online test with a score of 100%; you will be allowed to answer \
the questions as many times as needed)-20.3 ( )]TJ
0 -1.222 Td
[(to achieve a score of 100%.)-20 ( )]TJ
0 Tc 10.468 0 Td
( )Tj
-0.02 Tc -10.468 -1.222 Td
[(4. After successfully completing the test, your browser will be automati\
cally directed to the activity evaluation form,)-19.9 ( )]TJ
0 -1.222 Td
(which you will submit online.)Tj
0 -1.222 Td
(5. Once the completed evaluation is received, a credit letter will be em\
ailed to you.)Tj
ET
/CS0 cs 1 scn
/GS0 gs
163.412 729.88 392.33 17.367 re
f
BT
0 0 0 0 k
/TT0 1 Tf
0 Tc 12 0 0 12 294.7307 733.9762 Tm
(CME/CE INSTRUCTIONS)Tj
/CS0 cs 1 scn
0.01 Tc 9 0 0 9 164.4585 163.275 Tm
[(Upon completion of this educational activity)87.1 (, participants should be able to:)]TJ
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
0 Tc 7 0 0 7 26.64 742.5959 Tm
(PHYSICIAN EDITOR)Tj
( )Tj
/TT0 1 Tf
0 -1.214 Td
[(Michael H)17.9 (. Crawford, MD)]TJ
/TT1 1 Tf
0 -1.214 Td
[(P)35.7 (rofessor of Medicine)]TJ
0 -1.214 Td
[(L)17.4 (ucy Stern Chair in Cardiology)]TJ
0 -1.214 Td
(University of California)Tj
0 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/T1_0 1 Tf
0 -2.429 Td
(PEER REVIEWER)Tj
/TT0 1 Tf
0 -1.214 Td
(Susan Zhao, MD)Tj
/TT1 1 Tf
0 -1.214 Td
(Director )Tj
( )Tj
0 -1.214 Td
[(Adult Echocardiography L)17.3 (aboratory)]TJ
0 -1.214 Td
(Associate Chief)Tj
5.804 0 Td
( )Tj
-5.804 -1.214 Td
(Division of Cardiology)Tj
8.454 0 Td
( )Tj
-8.454 -1.214 Td
(Department of Medicine)Tj
0 -1.214 Td
[(Santa Clara V)53.9 (alley Medical Center)]TJ
/T1_0 1 Tf
0 -2.429 Td
(NURSE PLANNER)Tj
/TT0 1 Tf
0 -1.214 Td
[(Aurelia Macabasco)-18.9 (-)-36.5 (O)17.8 (\222Connell, PhD, )]TJ
0 -1.214 Td
[(A)17.5 (CNP)78 (-BC, RN, PHN, F)36.7 (AHA)]TJ
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor)]TJ
0 -1.214 Td
[(Azusa P)54.6 (acific University )]TJ
9.021 0 Td
( )Tj
-9.021 -1.214 Td
(School of Nursing)Tj
/T1_0 1 Tf
0 -2.715 Td
[(EDITORIAL ADVISOR)92.1 (Y BOARD)]TJ
/TT0 1 Tf
0 -1.214 Td
[(Jamie L. W)123.9 (. K)17.8 (ennedy)87.4 (, MD, F)35.6 (A)17.5 (CC)]TJ
( )Tj
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor)]TJ
( )Tj
0 -1.214 Td
(Division of Cardiology)Tj
8.454 0 Td
( )Tj
-8.454 -1.214 Td
[(Advanced Heart F)35.4 (ailure )]TJ
( )Tj
0 -1.214 Td
[(& T)155.6 (ransplant Cardiology)]TJ
9.12 0 Td
( )Tj
-9.12 -1.214 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/TT0 1 Tf
0 -2.429 Td
(Joshua D. Moss, MD)Tj
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor )]TJ
( )Tj
0 -1.214 Td
(of Clinical Medicine)Tj
0 -1.214 Td
(Cardiac Electrophysiology)Tj
0 -1.214 Td
(Division of Cardiology)Tj
0 -1.214 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/TT0 1 Tf
0 -2.429 Td
(Jeffrey Zimmet, MD, PhD)Tj
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor of Medicine)]TJ
0 -1.214 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.214 Td
[(San F)54.9 (rancisco)]TJ
0 -1.214 Td
[(Director)100.5 (, Cardiac )]TJ
6.807 0 Td
( )Tj
-6.807 -1.214 Td
[(Catheterization L)16.4 (aboratory)]TJ
0 -1.214 Td
[(San F)54.9 (rancisco V)54.9 (A Medical Center)]TJ
/T1_0 1 Tf
0 -2.429 Td
(EDITOR)Tj
/TT1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 Td
(Jonathan Springston)Tj
/T1_0 1 Tf
0 -2.429 Td
(EDITOR)Tj
/TT1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 Td
(Jason Schneider)Tj
/T1_0 1 Tf
0 -2.429 Td
(EDITORIAL GROUP MANAGER)Tj
/TT0 1 Tf
0 -1.214 Td
(Leslie Coplin)Tj
/T1_0 1 Tf
0 -2.429 Td
[(ACCREDIT)74.1 (A)74 (TIONS DIRECTOR)]TJ
/TT2 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 Td
(Amy M. Johnson, MSN, RN, CPN)Tj
/CS0 cs 1 scn
/GS0 gs
/TT1 1 Tf
0.01 Tc 9 0 0 9 163.3912 149.5607 Tm
(\225 )Tj
/Span<>> BDC
( )Tj
EMC
0.862 0 Td
(discuss the most current information related to cardiac illness and the \
treatment of cardiac disease;)Tj
-0.862 -1.111 Td
(\225 )Tj
/Span<>> BDC
( )Tj
EMC
0.862 0 Td
[(explain the advantages and disadvantages, as well as possible complicati\
ons, of interventions to treat cardiac)10.2 ( )]TJ
-0.01 Tw 0 -1.111 Td
(illness;)Tj
0 Tw -0.862 -1.111 Td
(\225 )Tj
/Span<>> BDC
( )Tj
EMC
0.862 0 Td
[(discuss the advantages, disadvantages, and cost-effectiveness of new and\
traditional diagnostic tests in the)9.9 ( )]TJ
0 -1.111 Td
(treatment of cardiac illness; and)Tj
-0.862 -1.111 Td
(\225 )Tj
/Span<>> BDC
( )Tj
EMC
0.862 0 Td
(discuss current data regarding outpatient care of cardiac patients.)Tj
ET
endstream
endobj
43 0 obj
<>
endobj
44 0 obj
<>
endobj
45 0 obj
<>
endobj
46 0 obj
<>
endobj
47 0 obj
<>
endobj
56 0 obj
<>
endobj
57 0 obj
<>stream
H|y\SW'/$l▼$Zǵelձ3ZѩE[J]`u7q+hݪQk贁dn|νwν7~ݭ{!C>!